Research map: Psychiatric Safety of GLP-1 Receptor Agonists Across Type 2 Diabetes and Obesity: An Integrative Review

Back to the article

Papers in this map

  1. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes · Steven P. Marso · 2016 · 7637 citations · Cited by this paper
  2. Adherence to the 24 h Movement Guidelines and Type 2 Diabetes Risk in the SUN Project: A Prospective Cohort Study · 2026 · Related
  3. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes · Steven P. Marso · 2016 · 6910 citations · Cited by this paper
  4. Assessing and Predicting Medication Adherence and Diabetes Control Among African American Adults with Uncontrolled Diabetes · 2026 · Related
  5. The Prevalence of Comorbid Depression in Adults With Diabetes · Ryan J. Anderson · 2001 · 3947 citations · Cited by this paper
  6. Sexual Dimorphism in the Association Between Vitamin D and Depressive Symptoms in Diabetic Patients and the Mediating Role of BMI: A Cross-Sectional Study · 2026 · Related
  7. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes · A. Michael Lincoff · 2023 · 3058 citations · Cited by this paper
  8. From Device Data to Trusted Decision Support: Building the Foundation for AI in Hospital Insulin Management · 2026 · Related
  9. Under-Reporting of Adverse Drug Reactions · Lorna Hazell · 2006 · 1952 citations · Cited by this paper
  10. Negative Association of SGLT2 Inhibitors with Epilepsy Risk Compared with DPP-4 Inhibitors in Type 2 Diabetes: A Target Trial Emulation · 2026 · Related
  11. Depression and poor glycemic control: a meta-analytic review of the literature. · Patrick J. Lustman · 2000 · 1859 citations · Cited by this paper
  12. Circadian Regulation of Glucose Metabolism: Implications for Pathogenesis and Chronotherapy of Type 2 Diabetes · 2026 · Related
  13. Assessing Psychosocial Distress in Diabetes · William H. Polonsky · 2005 · 1598 citations · Cited by this paper
  14. Experiences, Needs, and Beliefs Regarding Footwear Among People with Diabetes Mellitus in Spain: A Qualitative Focus Group Study Protocol · 2026 · Related
  15. Depression and Type 2 Diabetes Over the Lifespan · Briana R. Mezuk · 2008 · 1569 citations · Cited by this paper
  16. Relationship Between Diabetes Stigma and Outpatient Medical Costs in Patients with Type 2 Diabetes: A Cross-Sectional Study · 2026 · Related
  17. Adolescent suicide and suicidal behavior · Jeffrey A. Bridge · 2006 · 1360 citations · Cited by this paper
  18. QSAR Insights into Antidiabetic Activity of Natural Sulfur-Containing Compounds · 2026 · Related
  19. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025 · Nuha A. ElSayed · 2024 · 1318 citations · Cited by this paper
  20. Functional Assessment in Diabetic Cognitive Impairment: A Scoping Review of Activities of Daily Living Screening Tools · 2026 · Related
  21. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association · Deborah Lee Young-Hyman · 2016 · 1083 citations · Cited by this paper
  22. Depression and Diabetes Treatment Nonadherence: A Meta-Analysis · Jeffrey S. Gonzalez · 2008 · 1076 citations · Cited by this paper
  23. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis · Arie Nouwen · 2010 · 765 citations · Cited by this paper
  24. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity · Aaron S. Kelly · 2020 · 713 citations · Cited by this paper
  25. Once-Weekly Semaglutide in Adolescents with Obesity · Daniel Weghuber · 2022 · 704 citations · Cited by this paper
  26. The link between depression and diabetes: the search for shared mechanisms · Calum D. Moulton · 2015 · 678 citations · Cited by this paper
  27. When Is Diabetes Distress Clinically Meaningful? · Lawrence Fisher · 2012 · 661 citations · Cited by this paper
  28. Diabetes and depression: Global perspectives · Leonard E. Egede · 2010 · 534 citations · Cited by this paper
  29. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database · Jean‐Louis Montastruc · 2011 · 521 citations · Cited by this paper
  30. Confounding by Indication: An Example of Variation in the Use of Epidemiologic Terminology · María Marqueta de Salas · 1999 · 475 citations · Cited by this paper
  31. The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies · Mohammad Khaledi · 2019 · 368 citations · Cited by this paper
  32. Assessment and Control for Confounding by Indication in Observational Studies · Bruce M. Psaty · 1999 · 358 citations · Cited by this paper
  33. Impact of Safety Alerts on Measures of Disproportionality in Spontaneous Reporting Databases · Alexandre E. Pariente · 2007 · 266 citations · Cited by this paper
  34. Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder · Julie Rask Larsen · 2017 · 244 citations · Cited by this paper
  35. Association of semaglutide with risk of suicidal ideation in a real-world cohort · William Jiaen Wang · 2024 · 243 citations · Cited by this paper
  36. The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy · Edy Kornelius · 2024 · 132 citations · Cited by this paper
  37. Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder · Markku Lähteenvuo · 2024 · 128 citations · Cited by this paper
  38. Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality · Georgios Schoretsanitis · 2024 · 103 citations · Cited by this paper
  39. Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database · Mansour A. Tobaiqy · 2024 · 86 citations · Cited by this paper

Source: OpenAlex (CC0)